CUSIP 122017106 · who reports it, how much, and how much it matters to them
41 of the 720 hedge fund managers we track reported shares of Burlington Stores, Inc. (NYSE: BURL) on Form 13F for 30 June 2026. Between them they reported USD 1.2bn. The largest position belongs to SRS Investment Management, at USD 341m. The manager with the most riding on it is Dorsal Capital Management, where it is 5.6% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | SRS Investment Management4 funds on PPLI.com | USD 341m | 3.1% |
| 2 | Alkeon Capital Management19 funds on PPLI.com | USD 185m | 0.2% |
| 3 | Dorsal Capital Management2 funds on PPLI.com | USD 158m | 5.6% |
| 4 | Marshall Wace LLP84 funds on PPLI.com | USD 72m | 0.1% |
| 5 | Millennium Management6 funds on PPLI.com | USD 60m | 0.0% |
| 6 | Sculptor Capital67 funds on PPLI.com | USD 57m | 0.5% |
| 7 | D. E. Shaw & Co.15 funds on PPLI.com | USD 55m | 0.0% |
| 8 | Balyasny Asset Management25 funds on PPLI.com | USD 49m | 0.1% |
| 9 | Squarepoint Ops7 funds on PPLI.com | USD 37m | 0.0% |
| 10 | Two Sigma Investments35 funds on PPLI.com | USD 26m | 0.0% |
| 11 | Scopus Asset Management5 funds on PPLI.com | USD 24m | 0.3% |
| 12 | Boothbay Fund Management2 funds on PPLI.com | USD 17m | 0.2% |
| 13 | Tudor Investment Corporation10 funds on PPLI.com | USD 11m | 0.0% |
| 14 | Capital Fund Management S.A.12 funds on PPLI.com | USD 9.9m | 0.0% |
| 15 | Shellback Capital1 fund on PPLI.com | USD 9.5m | 0.8% |
| 16 | Graham Capital Management18 funds on PPLI.com | USD 5.7m | 0.1% |
| 17 | Verition Fund Management3 funds on PPLI.com | USD 5.5m | 0.0% |
| 18 | Carlson Capital17 funds on PPLI.com | USD 5.4m | 1.1% |
| 19 | Citadel Advisors32 funds on PPLI.com | USD 5.4m | 0.0% |
| 20 | IFM Investors Pty7 funds on PPLI.com | USD 4.7m | 0.0% |
| 21 | Capricorn Fund Managers8 funds on PPLI.com | USD 4.1m | 0.3% |
| 22 | Landscape Capital Management4 funds on PPLI.com | USD 4.1m | 0.3% |
| 23 | III Capital Management13 funds on PPLI.com | USD 3.5m | 0.9% |
| 24 | Walleye Capital8 funds on PPLI.com | USD 2.9m | 0.0% |
| 25 | Aristides Capital2 funds on PPLI.com | USD 2.6m | 0.5% |
| 26 | Bridgewater Associates45 funds on PPLI.com | USD 2.4m | 0.0% |
| 27 | Masterton Capital Management1 fund on PPLI.com | USD 1.8m | 1.5% |
| 28 | Capstone Investment Advisors25 funds on PPLI.com | USD 1.7m | 0.0% |
| 29 | Engineers Gate Manager1 fund on PPLI.com | USD 1.5m | 0.0% |
| 30 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 1.5m | 0.1% |
| 31 | Neo Ivy Capital Management1 fund on PPLI.com | USD 1.4m | 0.3% |
| 32 | Brevan Howard Capital Management39 funds on PPLI.com | USD 1.4m | 0.0% |
| 33 | Armistice Capital1 fund on PPLI.com | USD 1.2m | 0.0% |
| 34 | Magnetar Financial93 funds on PPLI.com | USD 1m | 0.0% |
| 35 | CIBC Asset Management69 funds on PPLI.com | USD 936,000 | 0.0% |
| 36 | Lighthouse Investment Partners190 funds on PPLI.com | USD 898,000 | 0.0% |
| 37 | Jain Global1 fund on PPLI.com | USD 808,000 | 0.0% |
| 38 | Lecap Asset Management1 fund on PPLI.com | USD 545,000 | 0.2% |
| 39 | Grandeur Peak Global Advisors2 funds on PPLI.com | USD 255,000 | 0.1% |
| 40 | ISAM Funds (UK)1 fund on PPLI.com | USD 253,000 | 0.2% |
| 41 | Bayforest Capital1 fund on PPLI.com | USD 63,360 | 0.1% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Dorsal Capital Management | USD 158m | 5.6% |
| 2 | SRS Investment Management | USD 341m | 3.1% |
| 3 | Masterton Capital Management | USD 1.8m | 1.5% |
| 4 | Carlson Capital | USD 5.4m | 1.1% |
| 5 | III Capital Management | USD 3.5m | 0.9% |
| 6 | Shellback Capital | USD 9.5m | 0.8% |
| 7 | Aristides Capital | USD 2.6m | 0.5% |
| 8 | Sculptor Capital | USD 57m | 0.5% |
| 9 | Scopus Asset Management | USD 24m | 0.3% |
| 10 | Neo Ivy Capital Management | USD 1.4m | 0.3% |
Burlington Stores, Inc. trades under the symbol BURL on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is 122017106.
41 of the 720 hedge fund managers PPLI.com tracks reported Burlington Stores, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by SRS Investment Management (USD 341m), Alkeon Capital Management (USD 185m), Dorsal Capital Management (USD 158m), Marshall Wace LLP (USD 72m) and Millennium Management (USD 60m).
41 managers in our coverage reported it, and between them they run 885 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Dorsal Capital Management, where the position was 5.6% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Burlington Stores, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.